Jan Zedenius is a Senior Professor of Surgery with a focus on Endocrine Surgery at Karolinska Institutet's Department of Molecular Medicine and Surgery. He leads the Endocrine Surgery research group under Robert Bränström and serves as President of the International Association of Endocrine Surgeons (IAES). His research spans thyroid cancer, parathyroid disorders, and adrenal tumors, with emphasis on molecular diagnostics and prognostic markers. Email: jan.zedenius@ki.se Employment: 2017-2024 (Professor/Chief Physician), 2024-2025 (Senior Professor) Degree: Associate Professor (Docent) in Surgery, Karolinska Institutet, 1999 His work addresses critical challenges in endocrine tumor differentiation (e.g., thyroid vs. parathyroid nodules, TERT promoter mutations for cancer aggressiveness), clinical management of hyperparathyroidism, and molecular mechanisms in adrenal/paragangliomas. Recent articles highlight collaborations on radiopharmaceutical development and spatial transcriptomics to map tumor progression. Key article trends: 1) TERT mutations as diagnostic/prognostic tools; 2) DICER1 and DGCR8 in thyroid nodule classification; 3) Ki-67 and thyroglobulin as biomarkers; 4) Nuclear imaging advancements; 5) Multi-institutional clinical studies; 6) Preoperative diagnostic protocols. Scientific recognition includes leading the IAES and numerous grants from the Swedish Cancer Society. He supervises PhD students and contributes to clinical guidelines for adrenal incidentalomas and parathyroid adenomas.
Professor SUNA ERKILIÇ is affiliated with Gaziantep University Faculty of Medicine , Department of Medical Pathology. She is a leading expert in thyroid pathology and cytopathology , with a focus on diagnostic accuracy and molecular markers in cancer research. Core research areas: Thyroid neoplasms, cytopathologic techniques, molecular diagnostics Supervised 5+ theses on thyroid tumors, salivary gland cytology, and effusion diagnostics Recipient of Turk Patoloji Dergisi Yılın Danışmanları Ödülü (2017) Her 15 most recent publications (2024-2015) emphasize thyroid pathology, biomarker analysis (e.g., TROP2, EGFR), and diagnostic methodologies (Thinprep Imaging, FNAC evaluation). Studies span international collaborations across 10+ countries. Key contributions include: Books: Immunohistochemistry (2022), Thyroid FNA Cytology (2019) Scientific projects: Evaluation of TROP2/Annexin A1 in thyroid tumors, Ki-67/CK-6/CK-16 in cholesteatoma pathogenesis Active participation in European Congress of Pathology and National Pathology Congresses as speaker and researcher
Chiti Arturo is a Full Professor in the Department of Imaging and Radiotherapy at the School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. He serves as a doctoral advisor in the Molecular and Experimental Medicine program at Humanitas University for cycles 31-38 (2015-2022) and teaches Master's-level courses in Health Informatics ("Images in healthcare - radiomics") and undergraduate Radiobiology. His research spans critical areas of: Nuclear Medicine Radiology Oncology Molecular Imaging Radiotherapy Medical Imaging Recent publications reveal a pronounced focus on PET imaging innovations for cancer management, including motion correction in pediatric brain tumor studies, PSMA-based prostate cancer staging, and radiomic modeling for pancreatic adenocarcinoma. His work consistently addresses clinical validation of imaging biomarkers through multi-center trials, emphasizing quantitative analysis for treatment response assessment and nodal metastasis detection. With over 200 publications, Professor Arturo demonstrates sustained leadership in translating advanced imaging techniques—particularly PET/MRI and radioembolization dosimetry—into oncology applications, significantly contributing to protocol standardization in molecular imaging.
Emanuel Della Torre is a Tenured University Researcher (RTDA) in Rheumatology and Medical Director at the Immunology, Rheumatology, Allergology, and Rare Diseases Unit (UnIRAR) at San Raffaele Hospital in Milan, Italy. He has held affiliations with institutions such as the Ragon Institute (MGH, MIT, Harvard) and Harvard Medical School . Vita-Salute San Raffaele University Massachusetts General Hospital Harvard Medical School Education includes a PhD in Basic and Applied Immunology (2018), Specialization in Clinical Immunology and Allergology (2014), and Laurea in Medicine and Surgery (2008), all from Vita-Salute San Raffaele University. His research focuses on IgG4-Related Disease , autoimmune disorders, and rare rheumatological conditions. He has characterized IgG4-Related Disease as a world expert via Expertscape and published over 100 peer-reviewed articles with 6,000+ citations (H-index: 35). Key scientific awards include: FOREUM Career Research Grant Cariplo Grant for Young Researchers MyFirst AIRC Grant Collegio Ghislieri Award He serves as Associate Editor for 3 international journals and reviewer for over 50 journals . His work bridges clinical immunology, rheumatology, and cell biology, with leadership roles in the European Reference Network (ReCONNET) and EULAR .
Edward A Dauer is a Clinical Professor in the Department of Biomedical Engineering at the College of Engineering, University of Miami. His work spans biomedical and civil engineering disciplines, focusing on biomaterials development and material science applications. Biomedical Engineering: Scaffold design for immunomodulation and peripheral nerve repair Civil Engineering: Protein-modified biocementation and nanoparticle-reinforced construction materials His research in biomedical engineering includes 3D scaffold fabrication for fibroblastic reticular cell maintenance and autoimmune therapy, while environmental applications involve electrohydromodulation for phosphate recovery. Material science work covers Kevlar composites and Polyurethane scaffold characterization, with biocementation studies analyzing protein effects on calcium carbonate precipitation. Publication trends show expertise in interdisciplinary material design , with articles covering topics from diabetogenic T cell modulation to bioremediation and composite durability . Key methodologies include scaffold fabrication, electrochemical recovery systems, and microstructural analysis across biological and civil engineering applications.
Mohamed Ibrahim is a Professor in the Department of Teaching & Educational Leadership at Arkansas Tech University, specializing in 21st-century educational technology and pedagogical innovation. Focuses on high-impact practices (HIPs) in teacher training Investigates immersive technologies (VR/360-video) for reflective teaching Develops AI integration frameworks for engineering education Contributes to medical research on adenomyosis and sickle cell pain management His recent publications span digital learning environments, regenerative medicine, and RNA virus evolution. Ibrahim employs metacognitive strategies and learning analytics to enhance self-directed learning across multiple disciplines including: Teacher education curriculum design Language acquisition pedagogy Materials science for energy applications
Anders Höög is a Senior Lecturer at the Karolinska Institutet , affiliated with the Department of Oncology-Pathology and the Catharina Larsson's Group . His work spans biomedical laboratory science and cancer research, with a focus on endocrine tumors. Research Interests : Höög investigates molecular mechanisms in thyroid, parathyroid, and neuroendocrine cancers. His studies explore genetic mutations (e.g., TERT and MEN1 ), microRNA dysregulation, telomerase activity, and tumor suppressor gene inactivation. He also contributes to improving clinical diagnostics via immunohistochemistry and mutational screening. Article Trends : Recent publications highlight autophagy suppression in Merkel cell carcinoma, IGF2BP3 as a prognostic biomarker, and minimally invasive lymph node detection in thyroid cancer. His work integrates molecular genetics, epigenetics, and clinical pathology to identify diagnostic and prognostic indicators. Labs & Collaborations : Höög collaborates within Catharina Larsson's Group, focusing on endocrine tumor genetics and clinical outcomes. His research often involves multidisciplinary teams and translational studies bridging laboratory findings to patient care.
Eduard Baquero Salazar is a researcher at the Institut Pasteur, working within the NanoImaging Core facility. He specializes in structural virology with a focus on coronavirus research, HIV, and hepatitis E virus. Dr. Baquero Salazar is actively involved in teaching advanced microscopy techniques through courses on cryo-electron microscopy and serves as an instructor for multiple upcoming courses at the Institut Pasteur. His research interests include: Structural analysis of viral spike proteins and host receptor interactions Coronavirus entry mechanisms and evolution Antibody neutralization of viruses including HIV and hepatitis E Application of cryo-electron microscopy to virology research Dr. Baquero Salazar has published extensively since 2021, with research appearing in high-impact journals including Nature, Cell, Nature Nanotechnology, and Science Advances. His work demonstrates expertise in structural virology and has contributed significantly to understanding viral entry mechanisms and antibody neutralization processes across multiple viral systems. His notable scientific contributions include identifying bat coronaviruses with SARS-CoV-2-like receptor-binding domains that can infect human cells, elucidating mechanisms of viral entry through receptors like TMPRSS2, and characterizing broadly neutralizing antibodies against HIV. These findings have important implications for understanding viral pathogenesis and developing countermeasures. Dr. Baquero Salazar teaches the following courses at the Institut Pasteur: Cryo-Electronic Microscopy (2024-2026) Cryo-EM Single Particle Imaging (2026)
Ken Kazahaya, MD, MBA, FACS, FAAP is an Associate Professor of Clinical Otorhinolaryngology: Head and Neck Surgery at the Perelman School of Medicine of the University of Pennsylvania, and serves as Attending Physician in the Division of Pediatric Otolaryngology at Children’s Hospital of Philadelphia (CHOP). At CHOP he is Director of Pediatric Skull Base Surgery, Medical Director of the Hearing Implant Program, and Co-Lead Surgeon in the Pediatric Thyroid Center. Education & Training MBA – The Wharton School, University of Pennsylvania MD – University of Pennsylvania School of Medicine Internship in General Surgery – University of Pennsylvania Residency in Otorhinolaryngology–Head & Neck Surgery – University of Pennsylvania Fellowship in Pediatric Otolaryngology – Children’s Hospital of Philadelphia Mini-Fellowship in Facial Plastic & Reconstructive Surgery – Oregon Health & Science University Research & Clinical Interests Dr Kazahaya’s clinical and scholarly work centers on advanced pediatric otolaryngology. He is an international authority in cochlear implantation, otology and neurotology, pediatric skull-base surgery, and thyroid and parathyroid surgery in children. His research portfolio encompasses surgical outcomes in pediatric thyroid carcinoma, intraoperative neuromonitoring techniques, quality-of-life impacts of endocrine surgery in adolescents, and the molecular characterization of pediatric head-and-neck tumors. An active participant in multi-institutional consensus efforts, he has helped craft national guidelines on pediatric thyroid surgery and COVID-era otolaryngologic practice. Publication Trends Between 2018 and 2023 Dr Kazahaya has published extensively across Head & Neck , Thyroid , Journal of Clinical Endocrinology & Metabolism , Pediatric Blood & Cancer , and other high-impact journals. His recent work reveals three dominant themes: (1) refining surgical risk stratification and outcomes in pediatric differentiated thyroid carcinoma, (2) advancing intraoperative neural monitoring and parathyroid hormone assays to enhance safety in pediatric thyroidectomy, and (3) investigating the otolaryngologic manifestations and peri-operative management of COVID-19 in children. Scientific Awards & Honors U.S. News & World Report – Top Pediatric ENT-Otolaryngologists (2011) Philadelphia Magazine – Top Doctors (2008–2015) SJ Magazine – Top Docs for Kids (2007, 2009, 2014, 2021) Castle Connolly – America’s Top Doctors (2017) American Academy of Otolaryngology–HNSF Honors Award (2017) Quality Care Award, SENTAC (2005) Leadership & Grant Roles Dr Kazahaya sits on multiple national and international boards and committees, including the American Head & Neck Society Pediatric Endocrine Surgery Committee (Co-Chair), American Thyroid Association Surgical Affairs and Patient Education Committees, and the International Society for Otitis Media Scientific Committee. He regularly secures invited lectureships across North America, Europe, Asia-Pacific, and Latin America, reflecting sustained extramural support and collaborative grants in pediatric otolaryngology education and surgical innovation. Clinical & Research Teams He leads or co-leads several CHOP multidisciplinary programs: the Hearing Implant Program, Pediatric Thyroid Center, Pediatric Skull Base Surgery Program, Solid Tumor Program, Surgical Oncology Program, and the Head and Neck Disorders Program. These teams integrate specialists from oncology, endocrinology, audiology, speech pathology, and neuroradiology to deliver comprehensive care and conduct translational research.
Paola Mapelli is a Research Fellow at Vita-Salute San Raffaele University , affiliated with the Department of Diagnostic Imaging and Radiotherapy under the School of Medicine. Her role focuses on advanced imaging techniques and radiotherapy applications in oncology. Disciplinary Sector: IMAGING, RADIOTHERAPY AND NEURORADIOLOGY (MEDS-22/A) Contact: mapelli.paola@hsr.it Research Interests: Paola specializes in medical imaging and radiomics, particularly in oncology. Her work focuses on PET/MRI applications for brain tumors, prostate cancer, and pancreatic neuroendocrine tumors, with a strong emphasis on radiomics , motion correction , and spatial co-registration techniques to improve diagnostic accuracy and surgical planning. Publication Trends: Recent publications highlight her expertise in hybrid imaging modalities like [68Ga]Ga-PSMA-11 and [68Ga]Ga-RM2 PET/MRI, hypoxia pathway imaging using 18F-FAZA, and machine learning-driven analysis of tumor microenvironments. These works bridge clinical validation with computational imaging advancements. Labs & Collaborations: She actively collaborates on clinical trials and multidisciplinary projects involving cancer diagnostics, working with institutions publishing in Nuclear Medicine , Gastroenterology , and Bioengineering .
Dr. Katarzyna Jobin is a Junior Group Leader at the Chair of Microbiology and an associated member of the Institute of Systems Immunology at the University of Würzburg, Germany. Her research focuses on understanding the interplay between immune cells and the extracellular matrix (ECM) in the urinary tract during bacterial infections, particularly in the context of antibiotic resistance and host-directed therapies. 2025–Present : Junior Group Leader, University of Würzburg 2019–2025 : Postdoctoral Researcher, Max Planck Research Group, Institute of Systems Immunology, University of Würzburg 2014–2018 : PhD Studies, University of Bonn 2007–2013 : Master’s and Bachelor Program in Biology, Jagiellonian University Her research spans immunology, microbiology, and nephrology, addressing critical challenges in urinary tract infections (UTIs), immune-ECM interactions, and dietary influences on immunity. Key methodologies include flow cytometry, confocal microscopy, and intravital imaging to study immune dynamics in real-time. Recent publications highlight her work in systems immunology, including studies on CD8 T cell immunity, lymph node dendritic cell networks, and high-salt diet effects on immune responses. These contributions align with broader efforts to combat antibiotic resistance and improve sepsis management. Dr. Jobin’s expertise in immune regulation extends to roles in acute kidney injury research and bone marrow niche characterization, bridging infectious disease and metabolic immunology.
Alexandra Elsakova is a Junior Research Fellow in Molecular Immunology at the University of Tartu's Faculty of Medicine, Institute of Biomedicine and Translational Medicine. Holding a 0.50 FTE appointment since September 2025, she has maintained continuous research engagement with the university since August 2022 across fractional positions (0.50–1.00 FTE). Her academic foundation includes: MSc Bioengineering at University of Tartu (2020–present) Bachelor's in Biology/Biomedicine from Lobachevsky State University of Nizhny Novgorod (2016–2020) Exchange studies at University of Turku (2019) Elsakova's research integrates molecular immunology with electrochemical biosensor development. Primary focus areas include immune dysregulation in multiple sclerosis (particularly EBV signatures), autoantibody profiling in viral infections (SARS-CoV-2), and translational diagnostic tools. Her work bridges fundamental immune mechanisms with applied sensor technology for point-of-care antibody detection. Recent publications (2023–2025) reveal dual thematic streams: neuroimmunological investigations of viral triggers in autoimmune disorders, and electrochemical methodologies for sensitive antibody quantification. This synergy between immunological inquiry and biosensor innovation defines her emerging scholarly identity. No scientific awards or fellowships are documented in available records. She co-supervised Avishan Aghayari's 2024 Master's thesis on T-cell receptor dynamics in CVID patients post-vaccination. Elsakova actively contributes to major funded initiatives: the European Commission's €996,125 Systems Immunology/Aging project (2024–2027) and Estonian Research Council's €943,700 study on type I interferons in autoimmunity/COVID-19 (2021–2025), both led by Kai Kisand. Based in the Institute of Biomedicine and Translational Medicine, she operates within Kai Kisand's research ecosystem focusing on immune tolerance mechanisms, while collaborating across faculties through projects like the Faculty of Science and Technology's biosensor development work.
Samer Al-Saad serves as an Associate Professor in the Department of Medical Biology at UiT The Arctic University of Norway, Tromsø campus. He is an active member of the Research Group for Translational Cancer Research (IMB/IKM), contributing significantly to the university's cancer research profile through his work on molecular mechanisms and biomarker discovery in oncology. Dr. Al-Saad's research program focuses on critical areas in cancer biology, with particular emphasis on lung and prostate cancers. His work explores: Translational research bridging laboratory findings to clinical applications Identification and validation of prognostic and predictive biomarkers Tumor immunology and microenvironment characterization Molecular pathways influencing cancer progression and treatment resistance Gender-specific differences in cancer biology and outcomes MicroRNA expression patterns as diagnostic and prognostic tools Analysis of Dr. Al-Saad's publication history reveals a consistent focus on refining cancer staging and prognostication through novel biomarkers. His recent work particularly emphasizes immune cell infiltration patterns in non-small cell lung cancer, with multiple studies examining tertiary lymphoid structures, tumor-infiltrating lymphocytes, and immune checkpoint molecules as predictors of patient outcomes. He frequently employs advanced pathological techniques including multiplex immunohistochemistry to characterize the tumor microenvironment with high spatial resolution. Dr. Al-Saad maintains an extensive collaborative network, as evidenced by his numerous co-authored publications in high-impact journals. His research has practical implications for improving cancer diagnosis, prognosis, and potentially treatment selection through biomarker development, with recent contributions appearing in the New England Journal of Medicine, British Journal of Cancer, and Scientific Reports.
Ingrid Svensson is a Senior Lecturer at the Department of Biomedical Engineering, College of Engineering, Lund University. She contributes to academic development as an Educational Developer at the Academic Development Unit and leads the department as Head of Biomedical Engineering. Her research spans interdisciplinary areas including photon science, biomedical engineering, and sustainable development goals. Expertise in finite element modeling and magnetomotive ultrasound techniques Active in LTH’s Engineering Health and Photon Science and Technology profile areas Contributes to LU’s Light and Materials research initiatives Her research integrates biomedical engineering with fluid mechanics and medical materials, focusing on: Computational modeling of arterial wall dynamics Magnetic microbubble applications for lymph node imaging Advanced ultrasound techniques using magnetic nanoparticles Friction analysis in slip prevention studies Medical device development for knee motion monitoring Development of diagnostic imaging protocols Recent publications highlight her work in: Finite element method for vascular mechanics Magnetomotive ultrasound for contrast-enhanced imaging Multidisciplinary approaches to lymph node diagnostics Integration of inertial sensors with electromyography Her research outputs demonstrate strong connections between: Medical imaging and materials science Computational modeling and clinical applications Mechanical engineering principles and healthcare technology
Dr. Jiani Hu serves as an Associate Professor in the Department of Radiology at Wayne State University School of Medicine, where she conducts research at the MR Research Facility. Her work focuses on applying advanced MRI and MRS techniques to diagnose, prognose, and monitor lesions in neurological disorders and cancers using both human and small animal models. Her primary research areas include cardiac MRI radiomics for myocardial infarction risk stratification, glymphatic system investigations in aging and diabetes, and neuroimaging of cerebral waste clearance. She actively collaborates with Dr. Mark Haacke to develop non-invasive imaging biomarkers for clinical applications in cardiology and neurology. Analysis of her recent publications reveals dominant trends in cardiac tissue characterization using extracellular volume radiomics and glymphatic dysfunction studies linking vascular physiology to neurodegenerative disorders. Her surgical outcome meta-analyses on bariatric and gastric procedures demonstrate methodological versatility across clinical domains. As a key contributor to the MR Research Facility, Dr. Hu advances quantitative MRI methodologies with direct clinical translation potential. Her interdisciplinary work bridges engineering, data science, and medicine to address unmet needs in cardiovascular and neurological disease management.
